Rovalpituzumab MMAE Antibody

SKU: orb2665657

Description

Rovalpituzumab-MMAE is an anti-DLL3 antibody-drug conjugate (ADC) produced in CHO cells, with a predicted molecular weight of 145.02 kDa. This research-grade ADC is utilized in preclinical studies to investigate targeted therapies for small cell lung cancer (SCLC) in both in vitro and in vivo models.

Images & Validation

−

Key Properties

−

Antibody Type	Inhibitor Antibody
Molecular Weight	145 kDa
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols